SUBSCRIBE
SUBSCRIBE

Earnings

Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Business
Embattled Valeant to Finally Reorganize, CEO Urges Patience
August 9, 2016
 · 
2 min read
Takeda CEO Faces Increasing Pressure From Investors as His Closest Ally Retires
Business
In Revamp, Takeda to Now Focus on Three Therapeutic Areas and Concentrate R&D Activities in Japan and the U.S.
July 29, 2016
 · 
3 min read
How Biogen Makes Most of Its Cash
Business
Biogen CEO Steps Down Amid Stellar Q2 Financials, Hunt for New Leader Begins
July 21, 2016
 · 
3 min read
Business
BioDelivery Consolidating the Sales Force Size in Cost-Cutting Move
May 10, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Investors Disappointed as Merck & Co. Sales of Januvia and Remicade Fall Short
May 5, 2016
 · 
2 min read
Business
AstraZeneca PLC to Cut Jobs in $1.5 Billion Cost-Cutting Move, Will Double Down on Cancer
April 29, 2016
 · 
3 min read
Two Bay Area Diagnostic Companies Win Amgen's Golden Ticket
Business
Crystal Ball Gazing: Amgen’s Q1 Financials, What to Look For
April 26, 2016
 · 
3 min read
Biowarfare Company Emergent's Cancer Spinoff Aptevo Therapeutics to Employ 70 - 90 in Seattle
Business
Multiple Failed Trials Lead Chimerix to Slash 20% of Workforce
March 1, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Analysts Pick Apart Amgen’s Financials for More Insight into Company’s Plans and Expectations
February 24, 2016
 · 
4 min read
Pfizer and Allergan Execs Emphasize Joint Company’s Pipeline, Hint Job Cuts Will Be Minimal
Business
Vertex Withholds Specific Sales Guidance for CF Drug Orkambi Due to Lacking Patient Compliance Data
January 28, 2016
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
February 23, 2026
 · 
18 min read
Press Releases
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences
February 23, 2026
 · 
1 min read
Press Releases
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
 · 
1 min read
Press Releases
UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026
February 23, 2026
 · 
1 min read
Press Releases
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update
February 23, 2026
 · 
1 min read
Press Releases
ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded ANKTIVA® Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally
February 23, 2026
 · 
19 min read
Press Releases
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
February 23, 2026
 · 
18 min read
Press Releases
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026
February 23, 2026
 · 
1 min read
Press Releases
Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 23, 2026
 · 
17 min read
Press Releases
Almirall’s 2025 Results
February 23, 2026
 · 
9 min read
Press Releases
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
February 22, 2026
 · 
17 min read
Press Releases
Abbott declares 409th consecutive quarterly dividend
February 22, 2026
 · 
1 min read
Press Releases
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
February 20, 2026
 · 
1 min read
Press Releases
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
February 20, 2026
 · 
3 min read
Press Releases
Cantargia Publishes Full Year Report 2025
February 20, 2026
 · 
3 min read
Press Releases
Annual report 2025: ALK delivers 15% revenue growth and 26% EBIT margin
February 20, 2026
 · 
4 min read
Press Releases
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
February 19, 2026
 · 
16 min read
Press Releases
Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights
February 19, 2026
 · 
16 min read
Press Releases
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
February 19, 2026
 · 
19 min read
Press Releases
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
February 19, 2026
 · 
13 min read
Load More